New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
07:06 EDTINCYIncyte upgraded to Buy from Neutral at Lazard Capital
Lazard Capital upgraded Incyte with a $25 price target citing increased penetration estimates for Jakafi in myelofibrosi.
News For INCY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
13:54 EDTINCYIncyte volatility at historic low on tight six-month range
Subscribe for More Information
September 17, 2014
08:44 EDTINCYIncyte weakness creates buying opportunity, says Argus
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use